Indirect detoxification via glutathione conjugation of N-acetyl-p-benzoquinone imine

The indirect detoxification via glutathione conjugation of N-acetyl-p-benzoquinone imine (NAPQI) is a critical metabolic process for neutralizing the toxic byproduct of acetaminophen (paracetamol) metabolism. NAPQI is a highly reactive electrophile generated by the cytochrome P450 system, primarily CYP2E1, which can cause severe cellular damage if not promptly sequestered [PubChem]. Under normal physiological conditions, NAPQI is rapidly conjugated with reduced glutathione (GSH), either through a spontaneous chemical reaction or via catalysis by glutathione S-transferase (GST) enzymes, forming non-toxic mercapturic acid conjugates for renal excretion [Reactome, R-HSA-2161522]. However, in the event of an acetaminophen overdose, the liver's glutathione stores become exhausted, allowing NAPQI to accumulate and bind covalently to mitochondrial proteins and lipid membranes [StatPearls, 2023]. This covalent binding triggers a cascade of oxidative stress, loss of mitochondrial membrane potential, and centrilobular hepatic necrosis. The primary therapeutic strategy for managing this toxicity involves the administration of N-acetylcysteine (NAC), which serves as a precursor to replenish hepatic glutathione levels and restore the detoxification pathway [NIH, LiverTox]. Understanding this pathway is crucial for assessing the risk of drug-induced liver injury and the efficacy of antioxidant interventions.

Other names

NAPQI-GSH conjugationAcetaminophen detoxification pathwayGlutathione conjugation of NAPQIPhase II metabolism of acetaminophen

N-acetylcysteine (NAC) acts as a precursor for the synthesis of reduced glutathione (GSH). By increasing hepatic GSH stores, NAC facilitates the conjugation and neutralization of the reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI), preventing it from binding covalently to cellular proteins and causing hepatic necrosis [StatPearls, 2023; NIH, LiverTox].